Abiraterone
The question
To ask the Secretary of State for Health and Social Care, whether he has had discussions with his counterparts in (a) Scotland, (b) Wales and (c) Northern Ireland on equitable access to abiraterone acetate for high-risk, non-metastatic prostate cancer pat
Answered by Karin Smyth
Decisions on the availability of medicines in Scotland, Wales, and Northern Ireland are a matter for the devolved administrations.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →